Attached files
EXHIBIT 32.1
CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION
1350)
In connection with the Annual Report of
Aeolus Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the period ending
September 30, 2009, as filed with the Securities and Exchange Commission on
the date hereof (the “Report”), the undersigned, John L. McManus, Principal
Executive Officer of the Company, and Michael P. McManus, Principal Financial
and Accounting Officer of the Company, each certify pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of his knowledge:
|
1.
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
Date:
December 28, 2009
__/s/ John L.
McManus_______
John L.
McManus
President
and Chief Executive Officer
(Principal
Executive Officer)
Date:
December 28, 2009
__/s/ Michael P.
McManus_____________
Michael
P. McManus
Chief
Financial Officer, Treasurer and Secretary
(Principal
Financial and Accounting Officer)
THIS CERTIFICATION “ACCOMPANIES” THE
ANNUAL REPORT, IS NOT DEEMED FILED WITH THE SEC AND IS NOT TO BE INCORPORATED BY
REFERENCE INTO ANY FILING OF THE COMPANY UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED (WHETHER MADE BEFORE
OR AFTER THE DATE OF THE ANNUAL REPORT), IRRESPECTIVE OF ANY GENERAL
INCORPORATION LANGUAGE CONTAINED IN SUCH FILING. A SIGNED ORIGINAL OF THIS
CERTIFICATION HAS BEEN PROVIDED TO THE COMPANY AND WILL BE RETAINED BY THE
COMPANY AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF
UPON REQUEST.